Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 654Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Bristol Myers Squibb

02 1Cooper Pharma Limited

03 1JV Pharmland

04 1Orbit Lifescience

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

Brand Name : DAKLINZA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 30MG BASE

Packaging :

Approval Date : 2015-07-24

Application Number : 206843

Regulatory Info : DISCN

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

Brand Name : DAKLINZA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 60MG BASE

Packaging :

Approval Date : 2015-07-24

Application Number : 206843

Regulatory Info : DISCN

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

DACLATASVIR DIHYDROCHLORIDE

Brand Name : DAKLINZA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 90MG BASE

Packaging :

Approval Date : 2016-04-13

Application Number : 206843

Regulatory Info : DISCN

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

daklatasvirdihydroklorid

Brand Name : Daklinza

Dosage Form : FILM COATED PILL

Dosage Strength : 30 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

daklatasvirdihydroklorid

Brand Name : Daklinza

Dosage Form : FILM COATED PILL

Dosage Strength : 60 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Daclatasvir 30Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 30 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Daclatasvir 60Mg 28 Combined Oral Use

Dosage Strength : 28 cpr riv 60 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 30 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

daclatasvir

Brand Name : Daklinza

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 60 mg

Packaging : Calendar Gasket

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Daclatasvir

Brand Name :

Dosage Form : Tablet

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Daclatasvir

Brand Name :

Dosage Form : Tablet

Dosage Strength : 60MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Belarus

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Daclatasvir

Brand Name : DACATEC

Dosage Form : Tablet

Dosage Strength : 60MG

Packaging : Jar pack of 30's

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank